NAD+ × peptide partners — lab test, February 2026
Kovera Labs publishes a public verification portal. Any test attributed to this lab can be looked up and confirmed directly with the lab — so this result doesn't rest on our review alone.
This certificate carries no lookup code.
Test results
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
About this test
Label 750 mg · Lab measured 869.24 mg
116% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 217.3 mg using the measured mass, against 187.5 mg on the label — 16% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
Independent HPLC purity analysis of NAD+ from peptide partners, performed by Kovera Labs on February 7, 2026. Reported purity: 99.856%. Net content: 869.24 mg against 750 mg labeled (116% of label). Tested content exceeds the labeled amount by 16%. Endotoxins: PASS (≤0.5 EU/mL). Batch NBD202601. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Other lots of NAD+ from peptide partners
| Lot | Tested | Lab | Purity | vs label | Status |
|---|---|---|---|---|---|
| NDU202601 | 20 Jan 2026 | Chromate | 99.851% | 86% | Unverified |
| ND20250503 | 31 Jul 2025 | BioRegen | 99.76% | 171% | Unverified |
Batches this shop has published a certificate for, newest first. A lot whose printed value cannot identify a batch is not listed.
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion